abstract |
The present invention includes compositions and methods for treating stroke in sickle cell anemia (SCA) patients. In certain embodiments, the patient is administered a specific ENPP1-containing polypeptide or ENNP3-containing polypeptide, variant thereof, or variant fragment. |